Epoch Investment Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Epoch Investment Partners's HALO Position: Q2 2026 in Review
Epoch Investment Partners reduced its Halozyme (HALO) stake by 3.5% in Q2 2026, selling an estimated $2.72M and leaving 1,098,532 shares worth $86M. The position accounts for 0.49% of the portfolio, ranked #73.
Epoch Investment Partners first reported a position in HALO in Q4 2022 and has held it in 15 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Epoch Investment Partners held 1,098,532 shares of Halozyme worth $86M as of Q2 2026.
- Epoch Investment Partners sold 39,845 Halozyme shares in Q2 2026, an estimated $2.72M.
- Halozyme made up 0.49% of Epoch Investment Partners's portfolio in Q2 2026, its #73 holding.
- Epoch Investment Partners first reported a position in Halozyme in Q4 2022 and has held it in 15 quarters since.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.